nke
Long — Nike at $67 prices a trough earnings year while ignoring a credible brand turnaround under CEO Elliott Hill. FY2025 is the reset year: revenue declining mid-single-digits, EPS compressed ~35-40% to ~$2.20-2.40. But the playbook is sound — rebuild wholesale, restore product scarcity, invest in running innovation.
That intrinsic line rolls up bear, base, and bull by assigned weights — not one cherry-picked case. Plain English: "intrinsic value" means what the model says the stock is worth if the growth narrative mostly holds — not a promise.
report snapshot
Long — Nike at $67 prices a trough earnings year while ignoring a credible brand turnaround under CEO Elliott Hill. FY2025 is the reset year: revenue declining mid-single-digits, EPS compressed ~35-40% to ~$2.20-2.40. But the playbook is sound — rebuild wholesale, restore product scarcity, invest in running innovation. At 18x trailing and ~30x trough forward P/E (low end of 10-year range), the risk/reward skews favorably for a 12-month $85 target (+27% upside).
| Pillar | Weight | Assessment | Confidence |
|---|---|---|---|
| Brand Turnaround Execution | 25% | Hill's brand-first approach credible but early | Medium |
| Wholesale Channel Reset | 20% | Rebuilding with Foot Locker, Dick's — 2H FY26 stabilization | Medium-High |
| Margin Recovery Path | 25% | 44.6% GM with room to expand as markdowns fade | Medium-High |
| Competitive Position Defense | 20% | Share losses to On/HOKA/NB are real but addressable | Medium |
| China Recovery Optionality | 10% | Geopolitical risk but $7.5B revenue base intact | Low-Medium |
$50
$85
$110
variant perception & thesis
Contrarian Long: Nike at $67 prices in prolonged mediocrity, not brand destruction. At 18x trailing P/E on peak-ish FY2024 earnings and ~30x forward on trough FY2025E, the market has correctly identified the problems (brand heat decline, wholesale erosion, competitive share loss) but overcorrected. Elliott Hill's return as CEO after 32 years at Nike is the most credible leadership reset available. With $11.6B cash, $6.5B+ FCF, and an asset-light model, Nike has the runway to execute a 2-year turnaround. Target $85 (27% upside), conviction 5.5/10.
| Metric | Value | Assessment |
|---|---|---|
| Market Cap | ~$100B | Mid-cap territory for Nike — historically $200B+ |
| 52-Week Range | $52.28 - $97.07 | Trading lower third of range |
| EV/EBITDA | 12.1x | Below 10-year average of ~18x |
| FCF Yield | 6.5% | Attractive for branded consumer |
| Net Cash | +$3.7B | No balance sheet risk |
| Dividend Yield | 2.1% | 22 consecutive years of increases |
financial analysis
Nike's financial architecture is the turnaround's greatest asset. FY2024 delivered $51.36B revenue (flat YoY), 44.6% gross margin, and $6.56B FCF — robust metrics even in a down cycle. FY2025E is the designed trough (revenue declining mid-single-digits, EPS ~$2.20-2.40), but the balance sheet ($11.6B cash, $3.7B net cash) and asset-light model ($870M CapEx) provide multi-year runway for turnaround investment without capital structure risk.
| Income Statement | FY2022 | FY2023 | FY2024 | FY2025E |
|---|---|---|---|---|
| Revenue ($B) | $46.7 | $51.2 | $51.4 | ~$48-49 |
| YoY Growth | +5% | +10% | ~0% | ~-5% |
| Gross Margin | 46.0% | 43.5% | 44.6% | ~43-44% |
| Op Income ($B) | $6.68 | $6.94 | $7.08 | ~$5.5-6.0 |
| Op Margin | 14.3% | 13.5% | 13.8% | ~11-12% |
| Net Income ($B) | $5.14 | $5.56 | $5.70 | ~$3.3-3.6 |
| EPS | $3.23 | $3.61 | $3.73 | ~$2.20-2.40 |
| Balance Sheet (FY2024) | Value | Context |
|---|---|---|
| Cash & Equivalents | $11.6B | Ample liquidity for turnaround investment |
| Long-Term Debt | $7.9B | Investment grade (AA-); no near-term maturities of concern |
| Net Cash Position | +$3.7B | No balance sheet risk; can absorb 2-3 years of reset |
| Inventory | ~$7.5B | Elevated; Hill working down excess via pullbacks |
| CapEx | $870M | 1.7% of revenue — asset-light model |
| FCF | $6.56B | 12.8% margin; funds buybacks + dividends + investment |
valuation
DCF analysis yields a $75-85 fair value range, with probability-weighted target of $85. At $67, Nike trades at a meaningful discount to intrinsic value on our base assumptions (WACC 9.5%, terminal growth 3.0%). The reverse DCF implies either ~6.8% perpetual FCF growth or 11.2% WACC — neither extreme, confirming the market prices mediocrity rather than destruction. Scenario analysis spans $50 (bear) to $110 (bull), with asymmetric upside from current levels.
$50
$85
$110
| Metric | Nike (NKE) | Adidas (ADDYY) | VF Corp (VFC) | Deckers (DECK) |
|---|---|---|---|---|
| Market Cap | ~$100B | ~$45B | ~$6B | ~$23B |
| Revenue (LTM) | $51.4B | ~$24B | ~$11B | ~$4.3B |
| P/E (Trailing) | 18.0x | ~35x | NM (loss) | ~28x |
| EV/EBITDA | 12.1x | ~18x | ~14x | ~19x |
| Gross Margin | 44.6% | ~50% | ~52% | ~56% |
| Op Margin | 13.8% | ~5% | ~3% | ~22% |
| Revenue Growth | ~0% | ~5% | ~-10% | ~20% |
what breaks the thesis
The central risk is misdiagnosis: what if Nike's brand erosion is structural, not cyclical? The thesis assumes Hill can reverse the damage from the Donahoe era — but if consumer preference has permanently shifted toward On, HOKA, and New Balance, Nike's premium pricing power may not return. Secondary risks include macro deterioration, geopolitical disruption in China, and FX headwinds compounding the turnaround timeline.
| Risk | Probability | Impact | Risk Score | Mitigant | Early Warning |
|---|---|---|---|---|---|
| Brand erosion is structural, not cyclical | 30% | Very High | Critical | Monitoring Gen Z preference surveys; product launch reception; Nike app engagement metrics | Two consecutive quarters of declining DTC full-price mix |
| Turnaround takes 3+ years vs 18-24 month thesis | 40% | High | High | Balance sheet provides multi-year runway; position sized at 3% limits damage | FY2026 guidance below $3.00 EPS; wholesale partners not re-engaging |
| Competitor share gains accelerate (On, HOKA, NB) | 35% | High | High | Nike's $4B+ marketing budget and global distribution still provide structural edge | Running category market share dropping below 35%; lifestyle category losing to NB |
| Consumer recession / macro deterioration | 20% | High | Medium-High | Premium brands more resilient; FCF funds operations through downturn | Consumer confidence below 60; unemployment above 4.5% |
| China geopolitical disruption | 25% | Medium-High | Medium-High | China is 15% of revenue; diversified geographic base limits single-country risk | US-China trade escalation; consumer boycott signals; domestic brand share gains |
| FX headwinds (dollar strengthening) | 30% | Medium | Medium | 12-18 month hedge book delays impact; partially offset by input cost benefits | DXY above 110; EUR/USD below 1.00 |
| CEO execution risk (Hill fails to deliver) | 15% | Very High | Medium-High | Board has demonstrated willingness to act (fired Donahoe); Mark Parker as Exec Chairman provides continuity | Key lieutenant departures; strategy pivots within first 12 months |
fundamentals & operations
Nike is mid-pivot from Donahoe's DTC-first strategy back toward wholesale under CEO Elliott Hill. DTC revenue reached ~$21.5B (~45% of Nike brand sales), but the margin benefits came at the cost of wholesale partner alienation and market share erosion. Hill's early moves signal a rebalancing toward key wholesale accounts like Foot Locker and Dick's Sporting Goods, while preserving Nike.com and SNKRS app as digital flagships.
| Region | FY2024 Rev | % of Total | YoY Trend | Outlook |
|---|---|---|---|---|
| North America | $21.4B | 42% | Flat | Wholesale reset underway |
| EMEA | $13.6B | 26% | +MSD | Strongest region, football cycle |
| Greater China | $7.5B | 15% | Flat | Tariff/geopolitical overhang |
| APLA | $6.1B | 12% | +LSD | Steady growth, emerging mkts |
| Converse | $2.08B | 4% | -8% | Secular decline, strategic review |
competitive position
Nike remains the undisputed #1 in global athletic footwear with ~27-30% market share, but the gap is narrowing fast. On Holding and HOKA have been the primary share takers, each growing 30%+ annually from small bases, while New Balance has quietly built a $6.5B+ business on lifestyle credibility. Adidas is resurgent on Samba/Gazelle retro heat. Nike's brand heat among 18-24 consumers has measurably declined, with multiple surveys showing On and New Balance gaining preference share.
| Company | Revenue | Growth | Gross Margin | Key Strength | Threat Level |
|---|---|---|---|---|---|
| Nike | $51.4B | Flat | 44.6% | Scale, brand legacy, Jordan | — |
| On Holding | $2.5B | +30% | 60%+ | Premium running, LightSpray tech | High |
| HOKA | $1.8B | +30% | ~55% | Max cushion, crossover lifestyle | High |
| New Balance | $6.5B+ | +20% | ~50%E | Made in USA, cultural cachet | Medium-High |
| Adidas | EUR 23.7B | +11% | 50.8% | Retro cycle (Samba/Gazelle) | Medium |
| Asics | $4.5B | +18% | ~52% | Performance running credibility | Low-Medium |
market size & tam
Nike operates in a $400B+ global athletic footwear and apparel market growing at 5-7% CAGR, with athletic footwear alone at $150B+. The secular tailwind from athleisure adoption, health/wellness spending, and casualization of dress codes continues to expand the TAM. Nike realistically addresses ~$200B+ of this market through its footwear, apparel, and equipment segments across performance and lifestyle categories.
| Market Segment | Est. Size | Growth Rate | Nike Position | Nike Share |
|---|---|---|---|---|
| Performance Running | $35B | 8-10% | Losing ground to On/HOKA | ~20% |
| Basketball | $8B | 3-5% | Dominant (Jordan + Nike) | ~60% |
| Lifestyle/Athleisure Footwear | $80B+ | 7-9% | Strong but fragmenting | ~25% |
| Athletic Apparel | $200B+ | 5-6% | Top 3 globally | ~10% |
| Football/Soccer | $15B | 4-6% | Co-leader with Adidas | ~30% |
| Training/Fitness | $12B | 6-8% | Competitive with UA, Lulu | ~15% |
product & technology
Nike's product engine — once the industry's undisputed innovation leader — has lost momentum. The Air Max DN launch delivered mixed commercial results, the running category has ceded credibility to On's CloudTec/LightSpray and HOKA's max-cushion platforms, and Jordan brand ($7.1B) shows deceleration after years of oversaturation. Hill's product reset for FY2026 aims to cut SKUs ~25%, reinvest in performance running, and manage the Jordan lifecycle more carefully.
| Product/Initiative | Timeline | Category | Expected Impact | Confidence |
|---|---|---|---|---|
| Pegasus Premium | FY2026 H1 | Running | Re-establish running credibility | Medium |
| Air Max DN 2.0 | FY2026 H2 | Lifestyle | Iterate on mixed DN launch | Low-Medium |
| SKU Rationalization | FY2025-26 | All | -25% SKUs, higher avg margin | High |
| Jordan Release Pullback | FY2026 | Basketball/Lifestyle | Short-term rev hit, long-term health | Medium |
| Blueprint Running Platform | FY2026 H2 | Running | New midsole tech platform | Medium |
supply chain
Nike's 100% outsourced manufacturing model is both its greatest structural advantage and a concentrated risk. Vietnam (50%), Indonesia (25%), and China (20%) account for ~95% of footwear production. The asset-light model drives industry-leading ROIC (~30%+) by keeping capex at ~3-4% of revenue, but the COVID-era Vietnam factory shutdowns proved the model's vulnerability to regional disruption. Current tariff escalation adds a new dimension of risk.
| Country | % of Footwear | Key Suppliers | Risk Factor | Tariff Exposure |
|---|---|---|---|---|
| Vietnam | ~50% | Pou Chen, Chang Shin | COVID shutdown precedent | Medium — trade deal dependent |
| Indonesia | ~25% | Feng Tay, Pou Chen | Political stability risk | Low-Medium |
| China | ~20% | Various | Geopolitical, tariff escalation | High — active tariff risk |
| India | ~3% | Expanding | Infrastructure, scale-up | Low |
| Cambodia/Others | ~2% | Diversification targets | Scale limitations | Low |
catalyst map
Five catalysts define the turnaround arc from trough (FY2025) through validation (FY2027). The nearest catalyst is FY2025 earnings in June 2025, which sets the baseline for trough expectations. The 2026 FIFA World Cup is the marquee brand event. Between them, wholesale stabilization, new running platforms, and China recovery provide incremental proof points.
| Catalyst | Timing | Impact | Probability |
|---|---|---|---|
| FY2025 Q4 Earnings + FY2026 Guidance | Jun 2025 | Sets trough baseline; guidance tone is key signal | Certain |
| Wholesale Door Count Recovery | H2 FY2026 (Jan-May 2026) | Most visible external proof of turnaround | Probable |
| New Running Platform Launches | Fall 2025 - Spring 2026 | Product credibility in performance segment | Moderate |
| 2026 FIFA World Cup | Jun-Jul 2026 | Massive global brand visibility; Nike sponsors 10+ teams | Certain |
| China Recovery / Greater China Inflection | FY2026-2027 | Greater China was $7.2B in FY2022; recovery unlocks growth | Uncertain |
street expectations
The Street is cautiously constructive on Nike with a ~$80 average price target, implying ~19% upside from $67. The rating distribution (~15 Buy, 20 Hold, 5 Sell) reflects a "show me" posture — most analysts believe Hill's strategy is directionally correct but want to see execution proof in FY2026 wholesale sell-through and margin stabilization before upgrading. Short interest at 2-3% is modest, indicating bears are expressing the trade through options rather than outright shorts.
| Firm | Rating | Price Target | Key Thesis | Catalyst Watched |
|---|---|---|---|---|
| Morgan Stanley | Overweight | $98 | Brand recovery cycle, Hill execution | FY2026 GM inflection |
| Goldman Sachs | Buy | $92 | Wholesale channel reset undervalued | Foot Locker sell-through data |
| JP Morgan | Neutral | $78 | Right direction, needs proof | China macro, FY26 guidance |
| Barclays | Equal Weight | $75 | Margin pressure through FY2026 | Inventory levels, promo cadence |
| Bernstein | Underperform | $58 | Structural share loss thesis | Gen Z brand tracker data |
| UBS | Neutral | $72 | Balanced risk/reward at $67 | Wholesale order books |
earnings scorecard
FY2025 is a deliberately engineered trough year. Elliott Hill is accepting near-term pain to reset wholesale relationships, clean up inventory, and rebuild product heat. The scorecard framework below tracks whether the turnaround is working — focusing on leading indicators, not headline revenue.
| Period | Revenue | EPS | GM | Beat/Miss | Key Takeaway |
|---|---|---|---|---|---|
| Q3 FY2025 (Mar 25) | $11.3B | $0.54 | 43.0% | Beat EPS, miss rev | Deeper revenue trough but cost discipline improving |
| Q2 FY2025 (Dec 24) | $12.4B | $0.78 | 43.6% | Beat EPS, miss rev | Margin ahead of revenue recovery; inventory clean |
| Q1 FY2025 (Sep 24) | $11.6B | $0.70 | 43.2% | Miss on both | Hill's first quarter; turnaround costs weighed |
| Q4 FY2024 (Jun 24) | $12.6B | $0.99 | 44.7% | Slight beat | Inventory normalization; wholesale stabilizing |
| Q3 FY2024 (Mar 24) | $12.4B | $0.77 | 44.8% | In-line | China recovery signs; DTC struggles emerging |
alternative data
Technical and positioning signals paint a picture of a stock in no-man's-land. Down 63% from the November 2021 ATH of $179, NKE sits at $67 — well off the 52-week low of $52 but lacking momentum catalysts. Institutional holders are still present but underweight, shorts are not pressing, and the options market reflects moderate uncertainty.
| Level | Price | Significance | Action Implication |
|---|---|---|---|
| 52-Week Low / Major Support | $52 | Tested Oct 2024; held on Hill appointment news | Break below = structural breakdown; re-evaluate thesis |
| Near-Term Support | $60-62 | Volume-weighted support zone from Q1 2025 consolidation | Potential add zone if thesis intact |
| Current Price | $67 | Mid-range; no strong technical signal | Holding position at 3% weight |
| Resistance Zone 1 | $75-80 | Multiple failed rallies have stalled here | Breakout above $80 = momentum inflection |
| Resistance Zone 2 | $90-97 | 52-week high area; pre-turnaround selling climax | Sustained above $90 = thesis largely validated |
| Bull Target | $110 | Requires normalized earnings + re-rating | Full position exit zone |
historical analogies & timeline
From a trunk full of Japanese running shoes to a $100B+ enterprise. Nike's 60-year arc is defined by relentless brand storytelling, athlete partnerships that redefined sports marketing, and periodic reinvention — punctuated by the current challenge of recovering from a strategic misstep that cut the stock 63% from its all-time high.
| Year | Milestone | Significance |
|---|---|---|
| 1964 | Blue Ribbon Sports founded | Phil Knight and Bill Bowerman begin importing Onitsuka Tiger shoes; Knight sells from his car trunk at track meets |
| 1971 | Nike brand and Swoosh created | Carolyn Davidson designs the Swoosh for $35; the company pivots to its own brand |
| 1972 | First Nike shoes debut at Olympic Trials | Moon Shoe and Waffle Trainer establish Nike's innovation identity under Bowerman |
| 1978 | Blue Ribbon Sports officially renamed Nike, Inc. | Revenue surpasses $70M; international expansion begins |
| 1980 | IPO on NYSE | 50% US market share in running; public listing funds global ambitions |
| 1984 | Michael Jordan signs endorsement deal | Air Jordan launches 1985; becomes the most successful athlete endorsement in history, eventually a $7.1B sub-brand |
| 1988 | "Just Do It" campaign launches | Wieden+Kennedy creates one of the most iconic taglines in advertising history; Nike overtakes Reebok |
| 1996 | Tiger Woods signs; Nike enters golf | Aggressive category expansion beyond running and basketball |
| 2003 | Converse acquired for $309M | Adds heritage sneaker brand; Converse grows to $2B+ before recent struggles |
| 2006 | Mark Parker becomes CEO | Begins Nike's best era of product innovation: Flyknit, VaporMax, React, self-lacing HyperAdapt |
| 2017 | Consumer Direct Offense (CDO) launched | Nike begins DTC pivot, initially successful — Nike Digital grows to ~30% of Nike brand revenue |
| 2020 | John Donahoe becomes CEO | Tech executive accelerates DTC, cuts wholesale accounts; innovation pipeline slows |
| 2021 | Stock peaks at $179.10 (Nov) | Post-COVID demand surge masks strategic issues; $279B market cap peak |
| 2024 | Elliott Hill appointed CEO (Oct) | 32-year Nike veteran returns to reset strategy; stock at $67, brand-first turnaround begins |
management & leadership
Nike's leadership reset is the single most important catalyst for the stock. The October 2024 appointment of Elliott Hill — a 32-year Nike veteran who ran the commercial organization — signals a decisive return to product-centric, brand-first leadership after the Donahoe era's tech-exec missteps. CFO Matthew Friend provides continuity, while Executive Chairman Mark Parker ensures institutional memory at the board level.
macro sensitivity
Nike is a high-beta consumer discretionary name with outsized FX and trade-policy exposure. With 60% of revenue outside the US, a manufacturing base concentrated in Vietnam and China, and a product mix skewed to non-essential spending, the macro regime matters more for NKE than for most mega-caps.
| Scenario | Revenue Impact | Margin Impact | EPS Impact | Stock Price Estimate |
|---|---|---|---|---|
| Soft Landing (Base) | -2% to flat | GM stable ~44-45% | $2.20-2.40 FY25E trough | $80-90 |
| Mild Recession (3-6mo) | -5% to -8% | GM contracts 100-150bps from markdowns | $1.80-2.00 | $55-65 |
| Deep Recession (12mo+) | -10% to -15% | GM contracts 200-300bps; heavy promotional activity | $1.40-1.60 | $40-50 |
| Stagflation (high inflation + slow growth) | -5% to -10% | Input cost pressure + volume decline; GM down 200bps+ | $1.50-1.80 | $45-55 |
quantitative profile
NKE screens as expensive on trailing metrics but potentially cheap on normalized earnings. The 30x forward P/E reflects trough FY2025 earnings, not structural overvaluation. On a normalized basis (FY2027E EPS $4.00-4.50), the stock trades at 15-17x — a steep discount to the 10-year average of 28-32x. The quant signal depends entirely on whether normalization actually happens.
| Metric | Current | 5-Year Avg | 10-Year Avg | Sector Median | Interpretation |
|---|---|---|---|---|---|
| P/E (Trailing) | 18x | 32x | 30x | 22x | Cheap vs own history; premium vs sector on trough E |
| P/E (Forward) | 28-30x | 28x | 28x | 18x | Optically expensive but denominator is trough |
| EV/EBITDA | 14x | 20x | 19x | 13x | Reasonable; closer to fair value on this metric |
| P/FCF | 15x | 25x | 24x | 18x | Attractive if FCF normalizes to $6B+ |
| PEG Ratio | N/A (neg growth) | 1.2x | 1.3x | 1.5x | Not meaningful in trough year; watch FY26-27 |
| Price/Sales | 1.9x | 3.2x | 3.0x | 1.5x | Below own history but still above sector |
options & derivatives
The options market is pricing elevated uncertainty with a meaningful put skew. Implied volatility runs above realized, reflecting the binary nature of turnaround outcomes. The term structure steepens into earnings dates, and the skew tells us the market is paying up for downside protection — consistent with institutional hedging rather than speculative positioning.
| Expiration | 25-Delta Put IV | ATM IV | 25-Delta Call IV | Skew (Put-Call) | Context |
|---|---|---|---|---|---|
| 30-Day | 35% | 31% | 28% | +7pts | Near-term hedging demand; earnings proximity |
| 90-Day | 33% | 30% | 27% | +6pts | Moderate skew; covers next earnings cycle |
| 6-Month | 32% | 29% | 26% | +6pts | Turnaround timeline pricing; still elevated |
| 12-Month (LEAPS) | 30% | 28% | 25% | +5pts | Longer-dated flattening; market sees resolution |
| 18-Month | 29% | 27% | 25% | +4pts | Skew compresses; binary risk less dominant |
governance & accounting
Nike's dual-class share structure concentrates voting power with the Knight family. Phil Knight and his son Travis Knight control approximately 65% of voting power through Class B shares, making Nike effectively a controlled company. This structure enabled the decisive CEO swap but also limits minority shareholder influence on strategic direction.
| Director | Role / Expertise | Key Affiliation | Since |
|---|---|---|---|
| Mark Parker | Executive Chairman | Former Nike CEO (2006-2020) | 2006 |
| Elliott Hill | CEO, Director | 32-year Nike veteran | 2024 |
| Cathleen Benko | Lead Independent Director | Former Deloitte Vice Chairman | 2020 |
| Timothy Cook | Independent Director | Apple CEO | 2016 |
| John Rogers Jr. | Independent Director | Ariel Investments Chairman | 2022 |
| Michelle Peluso | Independent Director | Former CVS Health digital chief | 2023 |
| Peter Henry | Independent Director | NYU Stern Dean Emeritus | 2020 |
value framework
Nike's brand moat remains formidable but is under stress. The swoosh is a top-15 global brand valued at ~$33B, yet erosion in product innovation and wholesale relationships under the Donahoe era has narrowed the competitive gap. At $67, the stock prices in significant damage — the question is whether the moat is durable enough to support a recovery to $85+.
| Competitive Advantage | Strength | Durability | Key Risk |
|---|---|---|---|
| Global Distribution (190+ countries) | Very Strong | High | Wholesale repair needed after DTC over-rotation |
| Athlete Endorsements (~$4B/yr spend) | Dominant | High | Rising cost of top-tier talent |
| Innovation IP (Air, Flyknit, ZoomX, Forward) | Strong | Medium-High | Pipeline stalled 2020-2024; Hill prioritizing R&D restart |
| Scale Economics (>$51B rev) | Very Strong | High | Fixed cost leverage requires volume recovery |
| Digital Ecosystem (SNKRS, Nike App, NTC) | Moderate | Medium | Engagement metrics declining; membership needs refreshing |
| Jordan Brand ($7.1B standalone) | Unique | High | Deceleration from oversaturation of retro releases |
key value drivers
Four drivers will determine whether Nike's turnaround succeeds or fails. Brand rehabilitation under Hill is the prerequisite; wholesale channel rebuild is the most visible near-term signal; running innovation pipeline is the product proof point; and margin recovery is the financial confirmation. Each must show progress within 18-24 months for the thesis to hold.
capital allocation
Nike returns virtually all FCF to shareholders through buybacks and dividends while running an asset-light model. FY2024 saw $5.23B in share repurchases and $2.18B in dividends against $6.56B FCF — a total shareholder return exceeding 100% of free cash flow, funded partially from the $11.6B cash balance. The $18B buyback authorization and 22-year dividend growth streak provide a strong capital return floor even during the turnaround.
| Use of Cash (FY2024) | Amount | % of FCF |
|---|---|---|
| Share Repurchases | $5.23B | 80% |
| Dividends | $2.18B | 33% |
| Capital Expenditures | $870M | 13% |
| Total FCF | $6.56B | 100% |
| Total Shareholder Return | $7.41B | 113% — funded partially from cash balance |
timeline
NIKE, Inc., operates in Rubber & Plastics Footwear, listed on NYSE, with a market cap of $100B.
Revenue Evolution
| Period | Revenue | Growth |
|---|---|---|
| FY2021 | $44.5B | |
| FY2022 | $46.7B | +4.9% |
| FY2023 | $51.2B | +9.6% |
| FY2024 | $51.4B | +0.3% |
Current position: Long at {'base_score': 5.5, 'pillar_scores': {'brand-turnaround-execution': 5.0, 'wholesale-channel-reset': 6.0, 'margin-recovery-path': 6.5, 'competitive-position-defense': 5.5, 'china-recovery-optionality': 4.5}, 'weighted_score': 55, 'adjustments': [{'factor': 'CEO credibility premium', 'delta': 5}, {'factor': 'Earnings trough uncertainty', 'delta': -5}, {'factor': 'Asset-light balance sheet safety', 'delta': 3}, {'factor': 'Competitive share loss velocity', 'delta': -3}], 'final_score': 55}/100 conviction.